Impax patents expiration
1. Adrenaclick patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5665071 | IMPAX | Reloadable automatic or manual emergency injection system |
May, 2013
(10 years ago) | |
| US10166344 | IMPAX | Injection needle assembly |
Jan, 2025
(8 months from now) | |
| US10166334 | IMPAX | Medicine injection apparatuses |
Jan, 2025
(8 months from now) | |
| US7905352 | IMPAX | Kits containing medicine injection devices and containers |
Apr, 2027
(2 years from now) | |
Drugs and Companies using EPINEPHRINE ingredient
Market Authorisation Date: 25 November, 2009
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
More Information on Dosage
ADRENACLICK family patents
2. Twinject 0.15 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7297136 | IMPAX | Medicine injection devices and methods |
Jan, 2025
(8 months from now) | |
| US7621891 | IMPAX | Method and apparatus for delivering epinephrine |
Feb, 2025
(9 months from now) | |
Drugs and Companies using EPINEPHRINE ingredient
Market Authorisation Date: 25 November, 2009
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
More Information on Dosage
TWINJECT 0.15 family patents
3. Twinject 0.3 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7297136 | IMPAX | Medicine injection devices and methods |
Jan, 2025
(8 months from now) | |
| US7621891 | IMPAX | Method and apparatus for delivering epinephrine |
Feb, 2025
(9 months from now) | |
Drugs and Companies using EPINEPHRINE ingredient
Market Authorisation Date: 25 November, 2009
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
More Information on Dosage
TWINJECT 0.3 family patents